Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2025-12-25 @ 2:21 AM
NCT ID:
NCT05253534
Eligibility Criteria:
Inclusion Criteria:
Inclusion criteria for subject selection
* Those who have applied to the eye diseases clinic
* ≥18 years old
* Those diagnosed with primary open-angle glaucoma (POAG) before the study
* Recipients of standard drug therapy (defined in diagnostic and treatment guidelines) for POAG
* Patients deemed appropriate by the investigator to be included in the study after ophthalmological examination
* According to the results of intraocular pressure (IOP) measurement and visual field test, patients with target pressure and initial moderate visual field loss who were deemed appropriate for inclusion in the study by the investigator
* Patients who were informed about the study and agreed to participate in the study
* Those who agree to continue to use acceptable methods of contraception during the study
Exclusion Criteria:
\-
Exclusion criteria for selection of subjects
* Those with a history of trauma or inflammation in their eyes
* Those who have undergone intraocular surgery or laser in the last 6 months, excluding those who have had uncomplicated cataract surgery
* Presence of any retinal or neurological disease other than glaucoma, abnormal ocular motility preventing binocular fixation (eg, nystagmus, strabismus)
* Those with corneal transplants
* Advanced disc cupping (c/d ratio 0.8 and above)
* Large and severe perimetric defects (a central perimetric residual not greater than 10 central degrees)
* Advanced visual field damage (MD above 12 db)
* Dry/wet type age-related macular degeneration in one or both eyes
* Those who have had glaucoma surgery in the past, excluding laser
* Corneal dystrophies
* High myopia (more than 6 diopters)
* Peripheral retinal degenerations with risk of retinal detachment
* Keratitis
* Those with severe dry eye syndrome
* Those with neurological disorders (eg, epilepsy)
* Those with systemic diseases (eg, diabetic mellitus)
* Women who are pregnant supported by biochemical laboratory findings
* Patients with difficulties in understanding and adapting to the study
* Negative benefit/risk ratio determined by the investigator
* Participated in any clinical trial within the previous 30 days.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05253534
Study Brief:
Protocol Section:
NCT05253534